Select Publications
Journal articles
, 2025, 'DNA reference reagents isolate biases in microbiome profiling: a global multi-lab study', MSYSTEMS, http://dx.doi.org/10.1128/msystems.00466-25
, 2025, 'Gut microbial-derived 3,4-dihydroxyphenylacetic acid ameliorates reproductive phenotype of polycystic ovary syndrome', Imeta, 4, http://dx.doi.org/10.1002/imt2.70065
, 2025, 'Unravelling the Relationship between Obesity and Inflammatory Bowel Disease', Inflammatory Bowel Diseases, 31, pp. 2547 - 2560, http://dx.doi.org/10.1093/ibd/izaf098
, 2025, 'Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy', Proceedings of the National Academy of Sciences of the United States of America, 122, http://dx.doi.org/10.1073/pnas.2314258122
, 2025, 'The Circulating Methylome in Childhood-Onset Inflammatory Bowel Disease', Journal of Crohn S and Colitis, 19, http://dx.doi.org/10.1093/ecco-jcc/jjae157
, 2025, 'Comparison of different microbiome analysis pipelines to validate their reproducibility of gastric mucosal microbiome composition', Msystems, 10, http://dx.doi.org/10.1128/msystems.01358-24
, 2025, 'International consensus statement on microbiome testing in clinical practice', Lancet Gastroenterology and Hepatology, 10, pp. 154 - 167, http://dx.doi.org/10.1016/S2468-1253(24)00311-X
, 2025, 'Association of gut microbiota changes and disease activity in patients with Crohn's disease and ulcerative colitis: baseline data from the Australian IBD Microbiome study', JOURNAL OF CROHNS & COLITIS, 19, pp. i2425 - i2426, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1519
, 2025, 'Fat rich dietary habits: Further increasing IBD risk in first degree relatives', JOURNAL OF CROHNS & COLITIS, 19, pp. i356 - i356, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0192
, 2025, 'Gut microbiota changes are associated with type of advanced therapy in patients with Inflammatory Bowel Disease: baseline data from the Australian IBD Microbiome study', JOURNAL OF CROHNS & COLITIS, 19, pp. i2413 - i2415, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1514
, 2025, 'High fat diet drives increased dysbiosis in IBD compared to healthy controls', JOURNAL OF CROHNS & COLITIS, 19, pp. i2409 - i2409, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1511
, 2025, 'Impaired health-related quality of life is associated with alterations in gut microbiota signatures in patients with Inflammatory Bowel Disease: baseline data from the Australian IBD Microbiome study', JOURNAL OF CROHNS & COLITIS, 19, pp. i2422 - i2424, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1518
, 2025, 'Microbial signatures associated with Inflammatory Bowel Disease in Australia: baseline data from the Australian IBD Microbiome study', JOURNAL OF CROHNS & COLITIS, 19, pp. i2391 - i2392, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1501
, 2025, 'Multi-omic modelling of antibiotic perturbed faecal microbial communities demonstrates reduced microbial resilience in IBD', JOURNAL OF CROHNS & COLITIS, 19, pp. I2377 - I2377, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1493
, 2025, 'P1330 The gut microbiome at the onset of inflammatory bowel disease: A systematic review of the literature and unified bioinformatic synthesis of sequencing data from >1000 treatment naïve patients', Journal of Crohn's and Colitis, 19, pp. i2394 - i2395, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1504
, 2025, 'The interplay between dietary intake and disease activity in Australian adults with and without Inflammatory Bowel Disease', JOURNAL OF CROHNS & COLITIS, 19, pp. I1468 - I1468, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0933
, 2025, 'The primary sclerosing cholangitis and ulcerative colitis colonic mucosa defined through paired microbial and single-cell RNA sequencing', JOURNAL OF CROHNS & COLITIS, 19, pp. I557 - I557, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0335
, 2025, 'Unique faecal & oral microbiota signatures in first degree relatives of inflammatory bowel disease patients', JOURNAL OF CROHNS & COLITIS, 19, pp. i606 - i606, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0377
, 2025, 'Translational strategies for oral delivery of faecal microbiota transplantation', Gut, http://dx.doi.org/10.1136/gutjnl-2025-335077
, 2025, 'Mo1960: IMPAIRED HEALTH-RELATED QUALITY OF LIFE IS ASSOCIATED WITH ALTERATIONS IN GUT MICROBIOTA SIGNATURES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: BASELINE DATA FROM THE AUSTRALIAN IBD MICROBIOME STUDY.', Gastroenterology, 169, pp. S - 1243, http://dx.doi.org/10.1016/s0016-5085(25)03747-3
, 2025, 'Mucosal DNA and RNA virome alterations and their interactions with human RNA and microRNA transcriptomes in colorectal polyps.', eGastroenterology, 3, pp. e100194, http://dx.doi.org/10.1136/egastro-2025-100194
, 2025, 'Sa1795: GUT MICROBIOTA CHANGES ARE ASSOCIATED WITH TYPE OF ADVANCED THERAPY IN PATIENTS WITH IBD: BASELINE DATA FROM THE AUSTRALIAN IBD MICROBIOME STUDY', Gastroenterology, 169, pp. S - 532, http://dx.doi.org/10.1016/s0016-5085(25)02163-8
, 2025, 'Sa1921: IMPACT OF HIGH- AND LOW-EMULSIFIER DIETS ON GUT MICROBIOTA IN HEALTHY ADULTS', Gastroenterology, 169, http://dx.doi.org/10.1016/s0016-5085(25)02283-8
, 2025, 'Tu2093: DISTINCT MICROBIAL SIGNATURES ARE ASSOCIATED WITH PEDIATRIC INFLAMMATORY BOWEL DISEASE - BASELINE DATA FROM THE AUSTRALIAN IBD MICROBIOME STUDY', Gastroenterology, 169, http://dx.doi.org/10.1016/s0016-5085(25)04560-3
, 2025, 'Welcome to Gut Microbiology: A new platform for a thriving field', Gut Microbiology, 1, pp. 100001 - 100001, http://dx.doi.org/10.1016/j.gutmic.2025.100001
, 2024, 'Dietary Patterns and Fibre Intake Are Associated with Disease Activity in Australian Adults with Inflammatory Bowel Disease: An Exploratory Dietary Pattern Analysis †', Nutrients, 16, http://dx.doi.org/10.3390/nu16244349
, 2024, 'Optimised human stool sample collection for multi-omic microbiota analysis', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-67499-4
, 2024, 'Dietary Emulsifier Exposure in People with Inflammatory Bowel Disease Compared with Healthy Controls: Is There a Cause for Concern?', Inflammatory Bowel Diseases, 30, pp. 1241 - 1250, http://dx.doi.org/10.1093/ibd/izad318
, 2024, 'Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-081787
, 2024, 'Prebiotic selection influencing inflammatory bowel disease treatment outcomes: A review of the preclinical and clinical evidence', Egastroenterology, 2, http://dx.doi.org/10.1136/egastro-2023-100055
, 2024, 'Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: Advances and future directions', Egastroenterology, 2, http://dx.doi.org/10.1136/egastro-2023-100006
, 2024, 'Sa1887 IS DIVERSITY IMPORTANT IN THE GUT MICROBIOME AT IBD ONSET? A SYSTEMATIC REVIEW OF THE LITERATURE AND META-ANALYSIS OF ALPHA-DIVERSITY DATA', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)01772-4
, 2023, 'Mucin-microbiome signatures shape the tumor microenvironment in gastric cancer', Microbiome, 11, http://dx.doi.org/10.1186/s40168-023-01534-w
, 2023, 'HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis', Gastroenterology, 165, pp. 946 - 962.e13, http://dx.doi.org/10.1053/j.gastro.2023.06.034
, 2023, 'A systematic review, pairwise meta-analysis and network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in irritable bowel syndrome', European Journal of Gastroenterology and Hepatology, 35, pp. 471 - 479, http://dx.doi.org/10.1097/MEG.0000000000002519
, 2023, 'Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic Review', Pathogens, 12, http://dx.doi.org/10.3390/pathogens12020262
, 2023, 'Critical Assessment of Whole Genome and Viral Enrichment Shotgun Metagenome on the Characterization of Stool Total Virome in Hepatocellular Carcinoma Patients', Viruses, 15, pp. 53, http://dx.doi.org/10.3390/v15010053
, 2023, 'Sa1865 MUCIN-MICROBIOME SIGNATURES SHAPE THE TUMOUR MICROENVIRONMENT IN GASTRIC CANCER', Gastroenterology, 164, pp. S - 468, http://dx.doi.org/10.1016/s0016-5085(23)02079-6
, 2022, 'The role of the microbiome in the metabolic health of people with schizophrenia and related psychoses: cross-sectional and pre-post lifestyle intervention analyses', Pathogens, 11, pp. 1279, http://dx.doi.org/10.3390/pathogens11111279
, 2022, 'Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease—Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics', Journal of Clinical Medicine, 11, http://dx.doi.org/10.3390/jcm11206173
, 2022, 'Comprehensive Study of Antiretroviral Drug Permeability at the Cervicovaginal Mucosa via an In Vitro Model', Pharmaceutics, 14, http://dx.doi.org/10.3390/pharmaceutics14091938
, 2022, 'Review article: the future of microbiome-based therapeutics', Alimentary Pharmacology and Therapeutics, 56, pp. 192 - 208, http://dx.doi.org/10.1111/apt.17049
, 2022, 'The role of mucins in gastrointestinal barrier function during health and disease', Lancet Gastroenterology and Hepatology, 7, pp. 455 - 471, http://dx.doi.org/10.1016/S2468-1253(21)00431-3
, 2022, 'Redefining intestinal immunity with single-cell transcriptomics', Mucosal Immunology, 15, pp. 531 - 541, http://dx.doi.org/10.1038/s41385-021-00470-y
, 2022, 'Correction to: Redefining intestinal immunity with single-cell transcriptomics (Mucosal Immunology, (2021), 10.1038/s41385-021-00470-y)', Mucosal Immunology, 15, pp. 526 - 526, http://dx.doi.org/10.1038/s41385-022-00483-1
, 2022, 'Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination', Frontiers in Medicine, 9, http://dx.doi.org/10.3389/fmed.2022.770017
, 2022, 'Gut Mucosal Microbiome Signatures of Colorectal Cancer Differ According to BMI Status', Frontiers in Medicine, 8, http://dx.doi.org/10.3389/fmed.2021.800566
, 2022, 'The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?', Cellular and Molecular Gastroenterology and Hepatology, 13, pp. 857 - 874, http://dx.doi.org/10.1016/j.jcmgh.2021.08.013
, 2021, 'Inflammatory bowel disease and the gut microbiota', Proceedings of the Nutrition Society, 80, pp. 424 - 434, http://dx.doi.org/10.1017/S002966512100197X
, 2021, 'Next-generation sequencing as a clinical laboratory tool for describing different microbiotas: An urgent need for future paediatric practice', Archives of Disease in Childhood, 106, pp. 1035, http://dx.doi.org/10.1136/archdischild-2021-321683